Quantcast

Latest New England Journal Stories

2014-08-06 08:31:45

High unmet need addressed with first new approved treatment in eighteen years MISSISSAUGA, ON, August 6, 2014 /CNW/ - Health Canada has approved (Pr)ABRAXANE(®) for Injectable Suspension (paclitaxel powder for injectable suspension) (nanoparticle, albumin-bound [nab(®)] paclitaxel) for first-line treatment of adult patients with metastatic pancreatic cancer. The approval is welcome news for Canadians who are diagnosed with metastatic pancreatic cancer, and represents the first...

2014-07-31 17:36:22

Wellcome Trust Drug-resistant malaria parasites have spread to critical border regions of Southeast Asia, seriously threatening global malaria control and elimination programs, according to a study published in the New England Journal of Medicine. The study confirms that resistance to the world's most effective antimalarial drug, artemisinin, is now widespread in Southeast Asia. This is not the first, or even the second time the malaria parasite has developed resistance to front line...

2014-06-18 20:21:54

Loss-of-function mutations in APOC3 gene lower blood lipids and lower risk of coronary artery disease CAMBRIDGE, Mass., June 18, 2014 /PRNewswire/ -- By scouring the DNA of thousands of patients, researchers at the Broad Institute, Massachusetts General Hospital, and their colleagues have discovered four rare gene mutations that not only lower the levels of triglycerides, a type of fat in the blood, but also significantly reduce a person's risk of coronary heart disease -- dropping...

2014-05-08 09:47:04

A major new pediatric research study led by a Wayne State University researcher, funded by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (NIH) and published this week in the New England Journal of Medicine (NEJM), has "major implications" for the treatment of urinary tract infections (UTIs) in millions of American children. The largest study of its kind in the world, it provides convincing evidence that children with a common...

2014-04-11 11:01:29

Surgical decision making for sick, elderly patients should be orchestrated by a multidisciplinary team, including the patient, his or her family, the surgeon, primary care physician, nurses and non-clinicians, such as social workers, advocates Laurent G. Glance, M.D., in a perspective piece published today in the New England Journal of Medicine. For this group of patients, surgery can be very risky. Glance, professor and vice-chair for research in the Department of Anesthesiology at the...

2014-04-10 09:55:23

Findings from the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial, have revealed that adding the medication known as spironolactone (Aldactone) to existing therapy did not significantly reduce the composite time to either death from cardiovascular causes, surviving a cardiac arrest, or hospitaliization to manage heart failure in patients with heart failure and a preserved ejection fraction in a study funded by the National Heart, Lung and...

2014-03-20 23:01:51

Kanti Rai, MD, and Jacqueline Barrientos, MD, comment on study of new leukemia therapy. Lake Success, NY (PRWEB) March 20, 2014 Two North Shore-LIJ Cancer Institute doctors, world-renowned for their research in chronic lymphocytic leukemia (CLL), weigh in on a German study of a new drug therapy for CLL in the March 20 edition of the New England Journal of Medicine, the North Shore-LIJ Health System announced today. CLL is one of the most common forms of blood cancers, usually affecting...

2014-01-24 11:25:34

Results on test of Idelalisib suggest CLL may be treated without toxic chemotherapy Use of a twice-daily pill could turn a deadly blood cancer into a highly treatable disease, according to scientists at Weill Cornell Medical College who led a multinational research team. Their findings on the therapy for chronic lymphocytic leukemia (CLL), reported in the Jan. 22 issue of the New England Journal of Medicine, suggest that patients may be able to avoid having to take debilitating...

2014-01-23 11:29:46

A major trial aiming to cut the rate of tuberculosis (TB) among South Africa's gold miners did not reduce the number of cases or deaths from the disease, according to a study published in the New England Journal of Medicine. Researchers from the London School of Hygiene & Tropical Medicine say that the results demonstrate the scale of the TB problem in South African gold mines, and highlight the need for a "combination prevention" approach to improve TB control. The TB epidemic in...

2014-01-23 11:27:02

The U.S. should prepare for more outbreaks of illness and possible deaths from designer drugs including synthetic marijuana, according to the new research from the University of Colorado School of Medicine. The study, published in the New England Journal of Medicine, illustrates a wide range of dangers associated with these increasingly popular drugs. In the fall of 2013, the Colorado Department of Public Health and Environment learned of an unusually large increase in emergency...


Word of the Day
negawatt
  • A unit of saved energy.
Coined by Amory Lovins, chairman of the Rocky Mountain Institute as a contraction of negative watt on the model of similar compounds like megawatt.